A team of researchers reports that a specific chromatin mechanism—histone crotonylation governed by an ACSS2–KAT5 complex—can actively steer liver inflammation during metabolic disease progression. The findings, published in Nature Communications (2026), focus on how fatty liver–related disease can transition from MASLD to the more aggressive form, MASH, a step that is strongly linked to worsening immune-driven tissue injury.
In metabolic dysfunction–associated steatotic liver disease, prolonged lipid accumulation is not simply a passive storage problem. It creates a molecular environment that reshapes gene regulation in hepatocytes and immune-relevant pathways. The study identifies crotonylation of histone sites as a key epigenetic “switch” that tunes inflammatory gene programs in favor of disease escalation.
Mechanistically, the researchers show that ACSS2 (short-chain acyl-CoA synthetase family member) supplies substrates for crotonylation, while KAT5 (a lysine acetyltransferase family enzyme) enables the deposition of crotonyl marks on histones. Rather than acting as isolated components, ACSS2 and KAT5 form a functional complex that coordinates when and where crotonylation occurs across the genome.
Using cellular and molecular experiments, the team demonstrates that increased ACSS2–KAT5–dependent crotonylation correlates with elevated transcription of pro-inflammatory targets. These include gene networks that can promote cytokine signaling, leukocyte recruitment, and the inflammatory milieu associated with MASH.
The authors further connect crotonylation to chromatin accessibility and transcription factor engagement, suggesting that crotonyl marks help loosen or restructure chromatin at inflammatory loci. This epigenetic remodeling provides a plausible route by which metabolic stress is converted into durable inflammatory gene expression.
Importantly, the study frames crotonylation as a driver of transition, not merely a biomarker of disease state. When the ACSS2–KAT5 axis is perturbed, the inflammatory transcriptional program shifts, implying that crotonylation contributes causally to progression from MASLD to MASH.
Together, the results position histone crotonylation as a tractable target within the broader epigenetic control of liver inflammation. Because crotonylation is tied to metabolite availability and specific writer enzymes, the pathway may offer intervention points that could complement metabolic therapies.
The work also underscores a viral-news-style message: the inflammatory destiny of the liver may be encoded in reversible chemical tags on histones—tags that can be written by a defined enzymatic complex and erased by future therapeutic strategies.
Whether targeting ACSS2, KAT5, or the crotonylation machinery upstream signals, the ACSS2–KAT5 complex emerges as a central node in the molecular circuitry of MASH progression.
Subject of Research: Liver inflammation epigenetics in the progression from MASLD to MASH via histone crotonylation
Article Title: ACSS2-KAT5 complex-driven histone crotonylation orchestrates a pro-inflammatory program to promote the transition from MASLD to MASH.
Article References: Wen, X., Wu, K., Wang, M. et al. ACSS2-KAT5 complex-driven histone crotonylation orchestrates a pro-inflammatory program to promote the transition from MASLD to MASH. Nature Communications (2026). https://doi.org/10.1038/s41467-026-75819-7
Image Credits: AI Generated
DOI: 10.1038/s41467-026-75819-7
Keywords: Histone crotonylation; ACSS2; KAT5; epigenetic regulation; MASLD; MASH; liver inflammation; pro-inflammatory gene program
Tags: ACSS2-KAT5 complexchromatin remodeling in metabolic diseasesepigenetic regulation in liver diseasegene regulation in hepatic inflammationHistone crotonylationhistone modification in inflammationimmune response in fatty liver diseaseliver inflammationMASLD to MASH progressionmetabolic dysfunction-associated steatotic liver diseasemolecular mechanisms of NASH development
